Definition
David M. Holtzman is an American neurologist and neuroscientist recognized for his contributions to the study of neurodegenerative disorders, particularly Alzheimer’s disease. He holds a professorship at Washington University School of Medicine in St. Louis and leads research on the molecular mechanisms underlying brain aging and dementia.
Overview
Holtzman serves as the Jack and Margaret Sweet Professor of Neurology, Pathology, and Molecular Biology at Washington University School of Medicine. He is also the director of the university’s Center for Neurodegeneration and Repair. His research program investigates the roles of amyloid‑β peptide, tau protein, and neurovascular dysfunction in the onset and progression of Alzheimer’s disease. The work emphasizes the interplay between vascular health, inflammation, and protein aggregation, employing approaches that include mouse genetics, advanced imaging, and human clinical studies. Holtzman’s findings have contributed to the development of therapeutic strategies targeting amyloid clearance, immune modulation, and blood‑brain barrier integrity. He has authored numerous peer‑reviewed articles and is frequently cited in the field of neurodegeneration.
Etymology / Origin
- David – A personal name of Hebrew origin meaning “beloved.”
- Holtzman – A surname of Germanic origin derived from Holz (“wood”) and Mann (“man”), historically indicating an occupation related to woodwork or a residence near a forest.
Characteristics
- Research Focus: Molecular and cellular mechanisms of Alzheimer's disease, including amyloid‑β metabolism, tau pathology, neuroinflammation, and cerebrovascular impairment.
- Methodological Expertise: Utilization of transgenic mouse models, in vivo two‑photon microscopy, proteomics, and translational studies involving human brain tissue and biomarkers.
- Academic Leadership: Directs interdisciplinary teams, secures major funding from agencies such as the National Institutes of Health, and mentors graduate students and postdoctoral fellows.
- Professional Service: Serves on editorial boards of leading neuroscience journals, participates in advisory panels for governmental and non‑governmental research agencies, and contributes to scientific societies focused on neurology and aging.
- Public Impact: Provides expert commentary for media outlets on emerging Alzheimer’s research and contributes to public‑health discussions regarding dementia prevention and treatment.
Related Topics
- Alzheimer’s disease
- Amyloid‑β peptide
- Tau protein pathology
- Neuroinflammation
- Cerebrovascular dysfunction and the blood‑brain barrier
- Washington University School of Medicine
- Neurodegeneration research methodologies
- Translational neuroscience.